Cerevel Therapeutics to Report Fourth Quarter and Full Year
CAMBRIDGE, Mass., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to
Globe Newswire1-02-2023, 18:39
Debate in in Milan Luiss University hub explores the Tax Reform: moving towards Cooperative Compliance 22-06-2023, 22:24